KUALA LUMPUR, May 19 -- Taconic Biosciences, a drug discovery animal model solutions provider, has successfully implemented its Rapid Restart™ programme, specifically to aid laboratories transitioning back to increased productivity.
According to a statement, Taconic was the first animal model provider in the industry to provide researchers with such programme, which was launched over a month ago.
Rapid Restart™ is a planning service that provides customers with a unique blend of flexible scheduling and availability assurances to ensure they have what they need, when they need it.
The planning precision afforded by the Rapid Restart™ programme honours Taconic’s commitment to animal welfare by reducing the gap between supply and demand.
“Customer feedback on the Rapid Restart™ programme has been overwhelmingly positive. Researchers from academia, biotechnology and pharmaceutical companies have expressed gratitude for Taconic’s willingness to partner during this unprecedented time,” said Taconic Biosciences vice-president of commercial products, Dr Michael Seiler.
Beyond commercially available animal models, Taconic also offers custom model generation and colony management solutions, which can play a role in how laboratories ramp back up capabilities.
-- BERNAMA
No comments:
Post a Comment